Loading
₹693.00
−0.40−0.06%today
Market closed · 7 Oct, 3:30 pm
−1.90%over 1 year
Today's range
₹686.10₹704.20
52-week range
₹575.80₹858.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 3,872 | 241 | 6.2% | 6.03 |
| FY25 | 3,004 | 385 | 12.8% | 9.61 |
| FY24 | 2,474 | 310 | 12.5% | 7.75 |
| FY23 | 2,168 | 336 | 15.5% | 8.41 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 32.50% | 34.11% | 34.11% | 34.11% |
| FIIs | 14.74% | 14.57% | 14.33% | 15.03% |
| DIIs | 34.43% | 32.50% | 32.71% | 32.12% |
| of which mutual funds | 28.52% | 27.41% | 27.50% | 26.72% |
| Public | 18.33% | 18.82% | 18.85% | 18.74% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Sai Life Sciences Ltd.SAILIFE | 1,558.70 | +0.04% | 33,110 |
| Dr. Lal Path Labs Ltd.LALPATHLAB | 1,938.00 | −1.33% | 32,529 |
| Krishna Institute of Medical Sciences Ltd.KIMS · this stock | 693.00 | −0.06% | 29,106 |
| Neuland Laboratories Ltd.NEULANDLAB | 21,610.00 | −1.35% | 27,725 |
| Piramal Pharma Ltd.PPLPHARMA | 202.67 | +1.07% | 26,982 |
| Rubicon Research Ltd.RUBICON | 1,570.00 | −1.68% | 25,989 |
| Acutaas Chemicals Ltd.ACUTAAS | 3,168.60 | +0.38% | 25,942 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.